Nautilus Bio

formerly Nautilus BiotechnologyIPO

Nautilus Bio is a biotech company in San Diego, United States, founded in 2016. It has raised $128.3M across 5 rounds, most recently a $14.7M Corporate Round in July 2021.

Reveal hidden biology

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$128.3M
Last Round
$14.7M Corporate RoundJul 2021
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 9 investors for this company. The full record is or through the API.

About

Nautilus Biotechnology (Nasdaq: NAUT) is a proteomics company, founded in 2016, that has built the Nautilus Voyager Platform using a technique called Iterative Mapping to achieve single-molecule quantification of proteins and proteoforms across the human proteome. Its technology targets pharmaceutical and academic researchers pursuing drug discovery, biomarker discovery, and exploratory biology, and the company runs research collaborations with academic partners such as Weill Cornell Medicine-Qatar and the Michael J. Fox Foundation.

Summary

It lists 51–200 employees. It has raised $128.3M in total across 5 rounds, most recently a $14.7M Corporate Round in Jul 2021. Investors include Arya Sciences Acquisition Corp III, Perceptive Advisors and Vulcan Capital.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundJul 2021
$14.7M

Sign up to see all 7 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
XpengIPO

Chinese manufacturer of smart electric vehicles combining AI driving and in-car systems for consu...

Guangzhou, China10001+Automotive, Autonomous Vehicles
Series CTotal funding$1.8BJul 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nautilus Bio on Indexed.vc
<a href="https://indexed.vc/companies/nautilus-bio"><img src="https://indexed.vc/api/badge/company/nautilus-bio" alt="Nautilus Bio on Indexed.vc" width="260" height="76" /></a>